9667

    540937

    MEDICO

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    MEDICO REMEDIES LIMITED Share Price Today

    MEDICO REMEDIES LIMITED is currently trading at ₹38.81, down by ₹0.05 from the previous close. The stock touched an intraday high of ₹39.48 and a low of ₹38.31 during the latest trading session. Over the past one year, MEDICO REMEDIES LIMITED has delivered a loss of 1.99%, while the stock has declined 9.59% in the last one month.

    MEDICO REMEDIES LIMITED performance

    Today’s low Today’s high
    ₹ 38.31 ₹ 39.48
    ₹ 38.81
    52 week low 52 week high
    ₹ 30.22 ₹ 56.88
    ₹ 38.81
    Open Price ₹ 39.44
    Prev. Close ₹ 38.87
    Volume (Shares) 83258.00
    Total traded value ₹ 32.31
    Upper Circuit ₹ 46.64
    Lower Circuit ₹ 31.10
    info

    Investment Returns

    Over 1 Month -9.59% Over 3 Months -5.98% Over 6 Months -17.65% Over 1 Year -1.99%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    MEDICO REMEDIES LIMITED fundamentals


    • Market cap (Cr) 322.10
    • P/E Ratio (TTM) 24.53
    • Beta 0.92
    • Book Value / share 9.09
    • Return on equity 17.57%
    • EPS (TTM) 1.58
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 5.86
    info icon alternate text
    • Market cap (Cr) 321.60
    • P/E Ratio (TTM) 24.53
    • Beta 0.79
    • Book Value / share 9.09
    • Return on equity 17.57%
    • EPS (TTM) 1.58
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 5.86
    info icon alternate text

    MEDICO REMEDIES LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 56.81
    Operating Expense 51.36
    Net Profit 5.86
    Net Profit Margin (%) 10.31
    Earnings Per Share (EPS) 0.71
    EBITDA 10.02
    Effective Tax Rate (%) 29.56
    Particulars DEC 2025 (Values in Cr)
    Revenue 58.68
    Operating Expense 55.53
    Net Profit 2.87
    Net Profit Margin (%) 4.89
    Earnings Per Share (EPS) 0.35
    EBITDA 5.01
    Effective Tax Rate (%) 25.06
    Particulars SEP 2025 (Values in Cr)
    Revenue 52.64
    Operating Expense 50.89
    Net Profit 2.57
    Net Profit Margin (%) 4.88
    Earnings Per Share (EPS) 0.31
    EBITDA 4.43
    Effective Tax Rate (%) 26.22
    Particulars JUN 2025 (Values in Cr)
    Revenue 38.25
    Operating Expense 36.47
    Net Profit 1.82
    Net Profit Margin (%) 4.75
    Earnings Per Share (EPS) 0.22
    EBITDA 3.48
    Effective Tax Rate (%) 25.51
    Particulars MAR 2025 (Values in Cr)
    Revenue 41.30
    Operating Expense 35.89
    Net Profit 4.34
    Net Profit Margin (%) 10.50
    Earnings Per Share (EPS) 0.52
    EBITDA 6.96
    Effective Tax Rate (%) 23.85
    Particulars MAR 2026 (Values in Cr)
    Revenue 206.38
    Operating Expense 194.25
    Net Profit 13.12
    Net Profit Margin (%) 6.35
    Earnings Per Share (EPS) 1.58
    EBITDA 22.95
    Effective Tax Rate (%) 27.35
    Particulars MAR 2025 (Values in Cr)
    Revenue 150.94
    Operating Expense 140.13
    Net Profit 10.09
    Net Profit Margin (%) 6.68
    Earnings Per Share (EPS) 1.22
    EBITDA 17.69
    Effective Tax Rate (%) 25.25
    Particulars MAR 2024 (Values in Cr)
    Revenue 144.92
    Operating Expense 135.70
    Net Profit 8.29
    Net Profit Margin (%) 5.72
    Earnings Per Share (EPS) 1.00
    EBITDA 15.03
    Effective Tax Rate (%) 26.83
    Particulars MAR 2023 (Values in Cr)
    Revenue 140.44
    Operating Expense 134.29
    Net Profit 7.24
    Net Profit Margin (%) 5.15
    Earnings Per Share (EPS) 0.87
    EBITDA 13.57
    Effective Tax Rate (%) 28.31
    Particulars MAR 2022 (Values in Cr)
    Revenue 121.02
    Operating Expense 116.56
    Net Profit 4.81
    Net Profit Margin (%) 3.97
    Earnings Per Share (EPS) 2.90
    EBITDA 9.36
    Effective Tax Rate (%) 25.77
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 7.53
    ROE % 17.57
    ROCE % 21.31
    Total Debt to Total Equity 0.20
    EBITDA Margin 11.72
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 6.31
    ROE % 17.23
    ROCE % 21.24
    Total Debt to Total Equity 0.19
    EBITDA Margin 10.37
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 5.28
    ROE % 18.00
    ROCE % 21.01
    Total Debt to Total Equity 0.28
    EBITDA Margin 9.66
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 22.04
    ROE % 13.93
    ROCE % 14.74
    Total Debt to Total Equity 0.40
    EBITDA Margin 7.73
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 78.22
    ROE % 8.31
    ROCE % 10.11
    Total Debt to Total Equity 0.46
    EBITDA Margin 5.12
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.09
    Total Assets 119.79
    Total Liabilities 119.79
    Total Equity 62.46
    Share Outstanding 8
    Price to Book Ratio 6.92
    Return on Assets (%) 8.42
    Return on Capital (%) 13.23
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.18
    Total Assets 96.19
    Total Liabilities 96.19
    Total Equity 52.37
    Share Outstanding 8
    Price to Book Ratio 7.81
    Return on Assets (%) 8.61
    Return on Capital (%) 14.02
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.91
    Total Assets 87.44
    Total Liabilities 87.44
    Total Equity 43.84
    Share Outstanding 8
    Price to Book Ratio 14.15
    Return on Assets (%) 8.28
    Return on Capital (%) 13.94
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.34
    Total Assets 77.40
    Total Liabilities 77.40
    Total Equity 36.57
    Share Outstanding 1
    Price to Book Ratio 3.81
    Return on Assets (%) 6.21
    Return on Capital (%) 10.2
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.83
    Total Assets 75.62
    Total Liabilities 75.62
    Total Equity 32.46
    Share Outstanding 0
    Price to Book Ratio 1.28
    Return on Assets (%) 3.42
    Return on Capital (%) 5.45
    Particulars MAR 2025 (Values in Cr)
    Net Income 13.50
    Cash from Operations 8.69
    Cash from Investing -3.45
    Cash from Financing -0.52
    Net change in Cash 0.91
    Free Cash Flow 8.69
    Particulars MAR 2024 (Values in Cr)
    Net Income 11.33
    Cash from Operations 5.60
    Cash from Investing -2.67
    Cash from Financing -0.49
    Net change in Cash -0.72
    Free Cash Flow 5.60
    Particulars MAR 2023 (Values in Cr)
    Net Income 10.09
    Cash from Operations 10.66
    Cash from Investing -6.60
    Cash from Financing -1.81
    Net change in Cash -0.25
    Free Cash Flow 10.66
    Particulars MAR 2022 (Values in Cr)
    Net Income 6.48
    Cash from Operations 7.65
    Cash from Investing -1.75
    Cash from Financing -5.77
    Net change in Cash -1.66
    Free Cash Flow 7.65
    Particulars MAR 2021 (Values in Cr)
    Net Income 2.59
    Cash from Operations -10.38
    Cash from Investing -16.96
    Cash from Financing 18.28
    Net change in Cash -9.99
    Free Cash Flow 6.58
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD. 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LTD. 431.50 19.03 3.12 1269.95 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2455.05 43.22 18.34 41590.03 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD. 482.50 52.16 4.42 5117.21 118.35 552.90

    MEDICO REMEDIES LIMITED shareholding pattern

    Holding
    38.59%
    61.38%
    0.02%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    MEDICO REMEDIES LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    38.81 -0.15 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 39.00
    • 26 Days 40.60
    • 10 Days 39.30
    • 50 Days 41.50
    • 12 Days 39.50
    • 100 Days 42.70
    • 20 Days 40.10
    • 200 Days 44.30
    39.16 PIVOT
    First Support 38.02 First Resistance 40.01 Second Support 37.17 Second Resistance 41.15 Third Support 36.03 Third Resistance 42.00
    RSI 36.99 ADX 49.69 MACD -1.10 Williams % R -57.99 Commodity Channel Index (CCI) -82.41
    Date 2026-07-17 Week 52875.00 Same Day 65672.00 Month 86536.00
    1 Year 0.93 3 Year 0.53
    Over 1 Month
    -9.59% down
    Over 1 Year
    -1.99% down
    Over 3 Months
    -5.98% down
    Over 3 Years
    -20.27% down
    Over 6 Months
    -17.65% down
    Over 5 Years
    9.90% down

    MEDICO REMEDIES LIMITED Corporate Actions

    Ex-Date Ex-Bonus Ratio
    17 Nov 2021 16 Nov 2021 3:1
    Ex-Date Old FV NEW FV Record Date
    16 Mar 2023 10.0 2.0 16 Mar 2023
    Ex-Date Ex-Bonus Ratio
    17 Nov 2021 16 Nov 2021 3:1
    Ex-Date Old FV NEW FV Record Date
    16 Mar 2023 10.0 2.0 16 Mar 2023

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Medico Remedies Ltd?

    Answer Field

    Medico Remedies Ltd share price is for NSE ₹ 38.81 & for BSE ₹ 38.75 as on Jul 17 2026 03:30 PM.

    What is the Market Cap of Medico Remedies Ltd Share?

    Answer Field

    The market cap of Medico Remedies Ltd for NSE ₹ 322.10 & for BSE ₹ 0.00 as on Jul 17 2026 03:30 PM.

    What is the 52 Week High and Low of Medico Remedies Ltd?

    Answer Field

    The 52 Week High and Low of Medico Remedies Ltd for NSE is ₹ 56.88 and ₹ 30.22 and for BSE is ₹ 56.99 and ₹ 31.00.

    What is 1 year return for Medico Remedies Ltd?

    Answer Field

    The 1 year returns on the stock has been -1.99%.

    What is the P/E Ratio of Medico Remedies Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM the price-to-earnings (PE) ratio for Medico Remedies Ltd share is 24.53.

    What is the PB ratio of Medico Remedies Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM, the price-to-book (PB) ratio for Medico Remedies Ltd share is 9.09.

    How to Buy Medico Remedies Ltd Share?

    Answer Field

    You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Medico Remedies Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Medico Remedies Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Medico Remedies Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |